From Name:
From Email:
To Name:
To Email:

Optional Message:


Drug combo good for metastatic melanoma

from Clinical Oncology

Patients with unresectable or metastatic BRAF V600E/K mutation–positive cutaneous melanoma fare better with dabrafenib and trametinib than with vemurafenib, results presented at the European Cancer Congress 2015 have shown. The findings are an extension of a Phase III trial, interim results of which were published earlier this year in The New England Journal of Medicine. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063